JESSICA SMOOT: Open Payments
NPI 1629825823 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 40 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $238 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $146 |
| Ionis Pharmaceuticals, Inc. | 2 | $49 |
| Lilly USA, LLC | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Boston Scientific Corporation | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 4 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: QULIPTA, MOUNJARO, Kerendia, VRAYLAR, REXULTI, FARXIGA, VOQUEZNA, UBRELVY.
Industry payments across ID — which companies pay providers there.
